Related references
Note: Only part of the references are listed.Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Roger S. McIntyre et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Subcutaneous Ketamine in Depression: A Systematic Review
Vitor Breseghello Cavenaghi et al.
FRONTIERS IN PSYCHIATRY (2021)
Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder A Pilot Study
Dorna Kheirabadi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review
Raheel Imtiaz Memon et al.
PSYCHIATRIC QUARTERLY (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Asberg Depression Rating Scale using the Structured Interview Guide for the MADRS
Fernando Fernandes et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
Somaye Arabzadeh et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Intramuscular ketamine in depression, suicidal thoughts and anxiety: A report on two cases
M. Cigognini et al.
EUROPEAN PSYCHIATRY (2017)
Ketamine for Depression, 3: Does Chirality Matter?
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
C. K. Loo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
Has psychiatry tamed the ketamine tiger? Considerations on its use for depression and anxiety
Keith G. Rasmussen
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries
S. Evans-Lacko et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2016)
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Milian et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate
Todd M. Hillhouse et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2015)
Risk factors for treatment resistance in unipolar depression: A systematic review
D. Bennabi et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection
Jing-fen Jin et al.
PATIENT PREFERENCE AND ADHERENCE (2015)
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
A. McGirr et al.
PSYCHOLOGICAL MEDICINE (2015)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013
David A. Mrazek et al.
PSYCHIATRIC SERVICES (2014)
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy
Caroline Caddy et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
New paradigms for treatment-resistant depression
Carlos Zarate et al.
ANNALS REPORTS (2013)
The Epidemiology of Depression Across Cultures
Ronald C. Kessler et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
Jason M. Dwyer et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression
Sarah M. Szymkowicz et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Repeated S-Ketamine Infusions in Therapy Resistant Depression: A Case Series
Felix Segmiller et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Using Measurement Strategies to Identify and Monitor Residual Symptoms
Roger S. McIntyre
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Case Report: Long-Term Mood Response To Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer
Claudia Grott Zanicotti et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Pharmacological prevention of suicide in patients with major mood disorders
Zoltan Rihmer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
Maurizio Pompili et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Intramuscular ketamine in acute depression: A report on two cases
Chilukuri Harihar et al.
INDIAN JOURNAL OF PSYCHIATRY (2013)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Staging methods for treatment resistant depression. A systematic review
Henricus G. Ruhe et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer
Claudia Grott Zanicotti et al.
JOURNAL OF PALLIATIVE MEDICINE (2012)
Treatment-resistant depression increases health costs and resource utilization
Beatrice Alinka Lepine et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2012)
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era
Noah S. Philip et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods
Paolo Girardi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods
Marcelo T. Berlim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2007)
Allocation concealment in randomised trials: defending against deciphering
KF Schulz et al.
LANCET (2002)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher et al.
LANCET (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
